This method detects genetic material (RNA) of the SARS-COV-2 virus from nasopharyngeal/oropharyngeal swab samples.

Our laboratory carries out the following tests for SARS-COV-2 coronavirus
Molecular testing (RT-PCR)

In our laboratory the testing is performed with the GenomEra® CDX analytical system of Abacus Diagnostica that offers high quality and reliability of results combined with a very short response time, following the protocol and guidelines of the World Health Organization (WHO).
The results are obtained in just 2-3 hours!
Rapid viral antigen detection test (Ag-RDT)

Rapid tests are performed on a nasal swab sample and offer a cost-effective and rapid method of detecting suspected cases. Our laboratory uses only approved tests that have high specificity and sensitivity providing reliable results.
IgG antibody detection test

Antibody testing is done by simple blood sampling. Antibody production is induced either after recent infection or after vaccination and their presence reaches detectable levels several days later (usually 1-3 weeks).
CAUTION: antibody testing is not appropriate to check if someone is now sick with COVID-19.
This test detects antibodies against the RBD antigen (Ag) within the S1 subunit of the spike (S) protein (glycoprotein – spike) of SARS-CoV-2, which is also the target on which all current vaccines are based. An increasing number of studies associate these antibodies with the neutralising capacity of the virus.
Our laboratory performs the following tests for SARS-COV-2 coronavirus
Molecular test (RT-PCR)

This method detects genetic material (RNA) of SARS-COV-2 virus from nasopharyngeal/ oropharyngeal smear samples.
In our laboratory the test is performed with the analytical system GenomEra®CDX by Abacus Diagnostica which offers high quality and reliability of results combined with a very short response time, following the protocol and instructions of the World Health Organization (WHO).
The results are received in just 2-3 hours!
Rapid virus antigen detection test (Ag - RDT) - Lateral Flow

Rapid tests are performed with a nasal swab sample and offer an economical and rapid method of detecting suspicious cases.
Our laboratory uses only CE-IVD approved tests that have high specificity and sensitivity, providing reliable results.
Test for IgG antibodies

Antibody testing is done by simple blood sampling. Antibody production is induced either after a recent infection or after vaccination and their presence reaches detectable levels several days later (usually 1-3 weeks).
ATTENTION: antibody testing is not indicated to check if someone is currently suffering from COVID-19.
This test detects antibodies to the (Ag) RBD antigen within the S1 subunit of the SARS-CoV-2 virus spike (S) protein (glycoprotein), which is also the target on which all current vaccines are based. An increased number of studies have linked these antibodies to the virus’s neutralizing ability.
- SARS-COV-2 coronavirus
-
Our laboratory carries out the following tests for SARS-COV-2 coronavirus
Molecular testing (RT-PCR)
This method detects genetic material (RNA) of the SARS-COV-2 virus from nasopharyngeal/oropharyngeal swab samples.
In our laboratory the testing is performed with the GenomEra® CDX analytical system of Abacus Diagnostica that offers high quality and reliability of results combined with a very short response time, following the protocol and guidelines of the World Health Organization (WHO).
The results are obtained in just 2-3 hours!
Rapid viral antigen detection test (Ag-RDT)
Rapid tests are performed on a nasal swab sample and offer a cost-effective and rapid method of detecting suspected cases. Our laboratory uses only approved tests that have high specificity and sensitivity providing reliable results.
IgG antibody detection test
Antibody testing is done by simple blood sampling. Antibody production is induced either after recent infection or after vaccination and their presence reaches detectable levels several days later (usually 1-3 weeks).
CAUTION: antibody testing is not appropriate to check if someone is now sick with COVID-19.
This test detects antibodies against the RBD antigen (Ag) within the S1 subunit of the spike (S) protein (glycoprotein – spike) of SARS-CoV-2, which is also the target on which all current vaccines are based. An increasing number of studies associate these antibodies with the neutralising capacity of the virus.
- Coronavirus SARS-COV-2
-
Our laboratory performs the following tests for SARS-COV-2 coronavirus
Molecular test (RT-PCR)
This method detects genetic material (RNA) of SARS-COV-2 virus from nasopharyngeal/ oropharyngeal smear samples.
In our laboratory the test is performed with the analytical system GenomEra®CDX by Abacus Diagnostica which offers high quality and reliability of results combined with a very short response time, following the protocol and instructions of the World Health Organization (WHO).
The results are received in just 2-3 hours!
Rapid virus antigen detection test (Ag - RDT) - Lateral Flow
Rapid tests are performed with a nasal swab sample and offer an economical and rapid method of detecting suspicious cases.
Our laboratory uses only CE-IVD approved tests that have high specificity and sensitivity, providing reliable results.
Test for IgG antibodies
Antibody testing is done by simple blood sampling. Antibody production is induced either after a recent infection or after vaccination and their presence reaches detectable levels several days later (usually 1-3 weeks).
ATTENTION: antibody testing is not indicated to check if someone is currently suffering from COVID-19.
This test detects antibodies to the (Ag) RBD antigen within the S1 subunit of the SARS-CoV-2 virus spike (S) protein (glycoprotein), which is also the target on which all current vaccines are based. An increased number of studies have linked these antibodies to the virus’s neutralizing ability.